Company Data
BioAtla Inc.
Ticker
BCAB
Current Price
$4.59 -6.52%
Market Cap
$7.6M
Price Target
Refer to Report
Volume
27.8K
52wk Range
$3.92 - $71.5
Overview
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise Mecbotamab vedotin, Ozuriftabmab vedotin, BA3071, and Bispecific antibody programs.